These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Tajouri L; Mellick AS; Ashton KJ; Tannenberg AE; Nagra RM; Tourtellotte WW; Griffiths LR Brain Res Mol Brain Res; 2003 Nov; 119(2):170-83. PubMed ID: 14625084 [TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. Lindberg RL; De Groot CJ; Certa U; Ravid R; Hoffmann F; Kappos L; Leppert D J Neuroimmunol; 2004 Jul; 152(1-2):154-67. PubMed ID: 15223248 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Koning N; Bö L; Hoek RM; Huitinga I Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969 [TBL] [Abstract][Full Text] [Related]
8. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Satoh J; Nakanishi M; Koike F; Miyake S; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Kanda T; Fukazawa T; Yamamura T Neurobiol Dis; 2005 Apr; 18(3):537-50. PubMed ID: 15755681 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery? Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K Neurobiol Dis; 2010 Mar; 37(3):613-21. PubMed ID: 19944761 [TBL] [Abstract][Full Text] [Related]
10. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels. Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542 [TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling in MS: what is the clinical relevance? De Jager PL; Hafler DA Lancet Neurol; 2004 May; 3(5):269. PubMed ID: 15099539 [No Abstract] [Full Text] [Related]
12. RNA profiling of MS brain tissues. Kinter J; Zeis T; Schaeren-Wiemers N Int MS J; 2008 Jun; 15(2):51-8. PubMed ID: 18782500 [TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes. Zeis T; Kinter J; Herrero-Herranz E; Weissert R; Schaeren-Wiemers N J Neuroimmunol; 2008 Dec; 205(1-2):10-9. PubMed ID: 18950873 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Junker A; Krumbholz M; Eisele S; Mohan H; Augstein F; Bittner R; Lassmann H; Wekerle H; Hohlfeld R; Meinl E Brain; 2009 Dec; 132(Pt 12):3342-52. PubMed ID: 19952055 [TBL] [Abstract][Full Text] [Related]